WIXLIB

Quality Forum’s Cancer Steering Committee. Prior to joining UnitedHealthcare, shewas the architect of the cancer care quality program at Anthem. Dr. Malin continuesher clinical practice by volunteering at the Veterans Affairs Greater Los Angeles HealthCare System. She lives in Santa Monica, California with her two children and threedogs.Angela MariottoNational Cancer InstituteAngela Mariotto is the Chief of the Data Analytics Branch (DAB) at the National CancerInstitute (NCI). Dr. Mariotto's work focuses on innovative methods and approaches toexpand the utility of cancer surveillance data. Her main areas of interest includedevelopment, improvement and modeling of cancer progress measures spanning thecancer continuum, such as, survival, prevalence, patterns of care and costs. She is theauthor of over papers. Dr. Mariotto received her PhD in Statistics from ImperialCollege, London, UK. Her passion is to fill gaps in data to make it more useful.Katie (Catherine) McMahonAmerican Cancer Society Cancer Action NetworkKatie (Catherine) McMahon is the Policy Principal for the American Cancer SocietyCancer Action Network, the nonprofit, nonpartisan advocacy affiliate of the AmericanCancer Society. Katie develops policy and provides in-depth analysis for legislative andregulatory priorities at all levels of government for cancer prevention and earlydetection. Katie was previously in the Office of the Assistant Secretary for Health atthe U.S. Department of Health and Human Services and at the Campaign for TobaccoFree Kids. Katie received her Bachelor of Arts and Master of Public Health from theGeorge Washington University.Jeri L. MillerNational Institute of Nursing ResearchJeri L. Miller, PhD, MS, MSc is the Chief of the Office of End-of-Life and Palliative CareResearch (OEPCR) at the National Institute of Nursing Research. The OEPCRcoordinates ongoing research efforts in end-of-life and palliative care scienceincluding: stimulation of research initiatives, creation of collaborative activities,facilitation of interdisciplinary science, and opportunities for science to inform policyand practice. A program priority is to develop end-of-life and palliative care initiativesin collaboration with other NIH Institutes and federal agencies.

Beverly MoyMassachusetts General Hospital Cancer CenterDr. Beverly Moy is the Director of Cancer Equity and Clinical Director of BreastOncology at the Massachusetts General Hospital and an Associate Professor ofMedicine at Harvard Medical School. Dr. Moy’s research interests include breastcancer clinical trials and cancer disparities. She served as Chair of the ASCO’s EthicsCommittee and Health Equity Committee. She has over 100 articles published inpeer-reviewed journals. She receives research grant funding from the National CancerInstitute, Trefler Foundation, and the Merck Foundation.Gila NetaNational Cancer InstituteGila Neta, PhD, MPP is an epidemiologist and program director for ImplementationScience in the Division of Cancer Control and Population Sciences at the NationalCancer Institute. Dr. Neta serves as the NCI scientific lead for the fundingannouncements in Dissemination and Implementation Research in Health andsupports research and training activities related to implementation science across theDivision. She has a secondary appointment within the Epidemiology and GenomicsResearch Program.Lauren Hersch NicholasUniversity of ColoradoLauren Hersch Nicholas is a health economist whose research focuses on the role ofpublic policy in improving health and healthcare quality for the elderly. Her currentresearch combines survey, administrative, and clinical data to study the interactionbetween healthcare utilization and economic outcomes. Dr. Nicholas's work usesclinical and econometric approaches to answer questions in medical and healtheconomics, particularly for dementia, surgery and end-of-life care. She has receivedseveral awards for her research including the National Academy of Social InsuranceJohn Heinz Dissertation Award, the AcademyHealth Article-of-the-Year Award, and theHCUP Most Outstanding Article Award.Michael PeskoGeorgia State UniversityMichael Pesko is a health economist and an Associate Professor in the Department ofEconomics at Georgia State University. Dr. Pesko’s research uses retrospectivelycollected data and quasi-experimental methods to evaluate health policy changes. Dr.Pesko has published over 40 peer reviewed papers. His research has been supportedby externally generated funds exceeding 2.8 million since 2016, including from NCI,NIDA, and the American Cancer Society.

Scott RamseyUniversity of WashingtonA Professor at Fred Hutchinson Cancer Research Center and University of Washington,Dr. Ramsey directs the Hutchinson Institute for Cancer Outcomes Research, which isdevoted to clinical and economic evaluations of cancer prevention, screening andtreatment. His research portfolio includes SEER-Medicare/Cancer Registry datalinkages, patient outcomes, economic modeling of interventions, cost-effectivenessanalysis, quality of life assessment, health care utilization, economic burden,pragmatic trial design, early technology assessment, and stakeholder engagement.Debra P. RitzwollerKaiser Permanente Institute for Health ResearchDebra P. Ritzwoller, PhD, is an Economist and Senior Investigator at the Institute forHealth Research and adjunct faculty in the Department of Health Systems,Management, and Policy at the University of Colorado School of Public Health. Herresearch focuses on variation in cancer screening, treatment, outcomes and costs incommunity settings; the impact of insurance benefit design on patient cost-sharing;and cost estimation within implementation science initiatives.Lindsay SabikUniversity of Pittsburgh Graduate School of Public HealthLindsay Sabik, PhD is an Associate Professor of Health Policy and Management at theUniversity of Pittsburgh Graduate School of Public Health, a Member of the UPMCHillman Cancer Center, and Director of the Workgroup on Cancer Health ServicesResearch within the Pitt Health Policy Institute. Her research investigates the impactsof state and federal policies on access to and quality of care for traditionallyunderserved patient populations across the cancer care continuum.Deb SchragDana Farber Cancer InstituteDeb Schrag, MD, MPH is Chief of the Division of Population Sciences at Dana FarberCancer Institute and Professor of Medicine at Harvard Medical School in Boston, MA.She is a health services researcher and gastrointestinal medical oncologist. Herresearch focuses on improving the quality, patient-centeredness, effectiveness, costeffectiveness and equity of cancer care delivery. She leads randomized trials, healthsystems interventions and has performed foundational work in patient-reportedoutcomes and phenomic data standards in order to improve cancer care.

Kosali SimonIndiana UniversityKosali Simon, a health economist, is Herman Wells Professor at Indiana University,Bloomington IN, O’Neill School of Public and Environmental Affairs, and also theAssociate Vice Provost of Health Sciences for the campus. She studies impacts of stateand federal health policies on health and related outcomes. She is Editor of Journal ofHealth Economics (JHE), and co-editor of Journal of Human Resources, and currentlyserving as Vice President of Association for Public Policy Analysis and Management(APPAM). She is a Research Associate of the National Bureau of Economic Research(NBER).Ya Chen Tina ShihUniversity of Texas MD Anderson Cancer CenterYa Chen Tina Shih, Ph.D., is professor and Chief of Section of Cancer Economics andPolicy, Department of Health Services Research at the University of Texas MDAnderson Cancer Center. Her research applies health econometric methods to studytechnology diffusion in cancer and modeling methods to evaluate cost-effectivenessof screening strategies. Dr. Shih is associate editor of Journal of the National CancerInstitute and is a member of the American Cancer Society Guidelines DevelopmentWorkgroup.Natasha K. StoutHarvard UniversityNatasha K. Stout, Ph.D., is Associate Professor in Population Medicine at the HarvardMedical School and Harvard Pilgrim Health Care Institute. Her research focuses onusing decision-analytic modeling and real-world electronic health data to design andevaluate breast cancer screening and control programs. Natasha is a member of theNCI’s Cancer Intervention and Surveillance Modeling Network (CISNET), acollaboration of independent modeling teams addressing policy questions in cancercontrol.Courtney WilliamsNational Cancer InstituteDr. Courtney Williams is a Cancer Prevention Fellow in the National Cancer InstituteHealthcare Delivery Research Program. Courtney’s current research promotespatient-centered care by focusing on issues related to financial hardship in olderindividuals living with cancer at the patient-, provider-, and policy-level. Courtneyearned her DrPH in outcomes research from the Department of Health CareOrganization & Policy and her MPH in epidemiology at the University of Alabama atBirmingham School of Public Health.

Karen WinkfieldMeharry-Vanderbilt AllianceDr. Karen Winkfield is a radiation oncologist specializing in the treatment ofhematologic and breast malignancies. She is an implementation scientist focused onimproving health outcomes for underserved populations through community-engagedresearch and community-based initiatives designed to improve access to healthcareincluding clinical trials. Her leadership roles have focused on developing bi-directionalcommunication between researchers and community to ensure equitable access tocare regardless of race/ethnicity, geographic location or socioeconomic states. Shealso espouses workforce diversity as a means to improve health equity Dr. Winkfieldserved as Chair of ASCO’s Health Equity Committee from 2016-2017 and now servesas Chair of the ASCO’s Workforce Diversity Task Force. She was recently namedExecutive Director of the Meharry-Vanderbilt Alliance.John WongTufts Medical CenterDr. John Wong is Chief Science Officer and Vice Chair of Clinical Affairs at TuftsMedical Center. A Professor of Medicine at the Tufts University School of Medicine, heis an Associate Statistical Editor at the Annals of Internal Medicine. His researchfocuses on the application of decision analysis to medical issues to help patients,clinicians, and policymakers choose among alternative tests, treatments or policies,thereby promoting rational evidence-based efficient and effective patient-centeredcare that reflects individualized risk assessment and patient preferences.Robin YabroffAmerican Cancer SocietyRobin Yabroff, PhD, is an epidemiologist and Scientific Vice President, Health ServicesResearch, at the American Cancer Society. She conducts research on financialhardship and economic burden of cancer; patterns of cancer care, including high costprescription drugs; health insurance benefit design; and patient, provider, and healthsystem factors associated with quality and value of cancer care. Dr. Yabroff has morethan 25 years of health services research experience and writes and speaks frequentlyabout cancer health economics.James B. YuYale UniversityJames B. Yu, MD, MHS, is a Professor of Therapeutic Radiology at the Yale School ofMedicine and Associate Chief Medical Officer for Radiation Oncology at SmilowCancer Hospital and Care Centers. As a member of the Cancer Outcomes, PublicPolicy, and Effectiveness Research (COPPER) Center at Yale, Dr. Yu’s research centerson the comparative effectiveness of new radiation technologies and how these newtechnologies are adopted nationally.

Yousuf ZafarDuke UniversityDr. Yousuf Zafar is a medical oncologist and Chief Quality & Innovation Officer at theDuke Cancer Institute. He is an associate professor of Medicine, Public Policy, andPopulation Health Science at the Duke Cancer Institute and Duke-Margolis Center forHealth Policy. Dr. Zafar explores ways to improve cancer care delivery with a primaryfocus on improving quality and value of cancer treatment from both patient-focusedand policy perspectives.Conference CommitteesPlanning CommitteeChair: Michael Halpern, MD, PhD, NCIDonatus (Don) Ekwueme, PhD, CDCYa Chen Tina Shih, PhD, University of Texas MD Anderson Cancer CenterRobin Yabroff, PhD, MBA, American Cancer SocietyOrganizing CommitteeChair: Michael Halpern, MD, PhD, NCICathy Bradley, PhD, University of ColoradoAmy Davidoff, PhD, NCIDonatus (Don) Ekwueme, PhD, CDCJoseph Lipscomb, PhD, Emory UniversityLindsay Sabik, PhD, University of PittsburghYa Chen Tina Shih, PhD, University of Texas MD Anderson Cancer CenterRobin Yabroff, PhD, MBA, American Cancer SocietyPrevention Planning GroupChair: Donatus (Don) Ekwueme, PhD, CDCMahima Ashok, PhD, Blue Shield of CaliforniaHarrell Chesson, PhD, CDCJeff Drope, PhD, University of Illinois ChicagoMichael Halpern, MD, PhD, NCIYoung-Rock Hong, PhD, University of FloridaDonald Kenkel, PhD, Cornell UniversityMichael Maciosek, PhD, HealthPartners InstituteMichael Pesko, PhD, Georgia State UniversityScreening/Diagnosis Planning GroupChair: Ya Chen Tina Shih, PhD, University of Texas MD Anderson Cancer CenterMichael Halpern, MD, PhD, NCIJoseph Lipscomb, PhD, Emory UniversityScott Ramsey, MD, PhD, University of WashingtonDebra Ritzwoller, PhD, Kaiser Permanente Institute for Health Research

Lindsay Sabik, PhD, University of PittsburghNatasha Stout, PhD, Harvard UniversityTreatment Planning GroupChair: Robin Yabroff, PhD, MBA, American Cancer SocietyMichael Halpern, MD, PhD, NCIHenry (Joe) Henk, PhD, OptumLabsDeb Schrag, MD, MPH, Dana Farber Cancer InstituteYa Chen Tina Shih, PhD, University of Texas MD Anderson Cancer CenterMarc Smaldone, MD, MSHP, Fox Chase Cancer CenterStephanie Wheeler, PhD, MPH, University of North Carolina at Chapel HillJames Yu, MD, MHS, Yale UniversitySurvivorship/Supportive Care Planning GroupChair: Cathy Bradley, PhD, University of ColoradoAmy Davidoff, PhD, NCIMichael Halpern, MD, PhD, NCIDavid Howard, PhD, Emory UniversityNancy Keating, MD, MPH, Harvard UniversityDebra Ritzwoller, PhD, Kaiser Permanente Institute for Health ResearchRobin Yabroff, PhD, MBA, American Cancer SocietySpecial Thanks To:Kaitlin Akif, NCIDenise Buckley, NCIDavid Chambers, NCIMegan Cole, Brown UniversitySherri Cook, NCIJoe Cotter, American Cancer SocietyRachel Eisinger-Baskin, NCIKortney Incorvaia, American Society of Preventive OncologyDeborah Kamin, American Society of Clinical OncologyErin Leahy, ICFBrandon Leonard, AACRCatherine Maclean, Temple UniversitySharon McCarthy, NCICrystal Reed, NCIJennifer Schaefer, ICFWilliam Schpero, Cornell UniversityHelen Sullivan, FDAJennifer Tsui, University of Southern CaliforniaPriyanga Tuovinen, NCIRobin Vanderpool, NCI

Cathy J. Bradley, Ph.D., is the Associate Dean for Research in the Colorado School of Public Health and the Deputy Director of the University of Colorado Cancer Center. She holds the Grohne Chair for Cancer Prevention and Control Research. Dr. Bradley is an internationally recognized expert in health services research and health economics,